NAYA Biosciences Stock (NASDAQ:NAYA)

Revenue Financials Chart

Previous Close

$2.03

52W Range

$1.38 - $17.04

50D Avg

$2.79

200D Avg

$7.48

Market Cap

$1.47M

Avg Vol (3M)

$116.04K

Beta

2.04

Div Yield

-

NAYA Company Profile

INVO Bioscience is a medical device company providing devices and products for infertility diagnosis. Its flagship product is INVOcell, a reproductive technology that allows fertilization and early embryo development to take place within the woman’s body.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

30

IPO Date

Nov 02, 2020

Website

NAYA Performance

NAYA Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$3.02M	$822.20K	$4.16M
Operating Income	$-6.77M	$-10.63M	$-5.22M
Net Income	$-8.03M	$-10.89M	$-6.65M
EBITDA	$-6.88M	$-10.75M	$-5.22M
Basic EPS	$-5.13	$-17.97	$-12.52
Diluted EPS	$-5.13	$-17.97	$-12.52

Fiscal year ends in Dec 23 | Currency in USD